Standout Papers

Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, ra... 2018 2026 2020 2023 218
  1. Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study (2018)
    Florence Duffaud, Olivier Mir et al. The Lancet Oncology
  2. Advances in the clinical management of uveal melanoma (2023)
    Richard D. Carvajal, Joseph J. Sacco et al. Nature Reviews Clinical Oncology

Immediate Impact

3 by Nobel laureates 13 from Science/Nature 60 standout
Sub-graph 1 of 22

Citing Papers

GZMK-expressing CD8+ T cells promote recurrent airway inflammatory diseases
2025 StandoutNature
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
2 intermediate papers

Works of Sophie Piperno‐Neumann being referenced

Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study
2017
Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas
2017

Author Peers

Author Last Decade Papers Cites
Sophie Piperno‐Neumann 3357 3407 1556 1652 214 6.7k
Xavier Sastre 1450 1927 693 812 76 4.1k
Catherine A. Billups 2416 1731 356 1945 164 5.8k
Bartosz Chmielowski 1765 4349 305 2542 179 6.8k
Pieter A. van der Velden 564 1679 1405 1802 84 6.8k
Sandra P. D’Angelo 3401 5755 166 1138 188 7.5k
Gaëlle Pierron 2438 1677 207 2694 157 5.9k
Brian H. Kushner 1713 1782 135 2283 183 6.6k
Rajmohan Murali 2101 4220 717 3062 172 8.3k
Sakari Knuutila 3123 2099 191 3932 248 9.4k
Véronique Mosseri 1145 2670 276 1877 122 7.2k

All Works

Loading papers...

Rankless by CCL
2026